About
Syed Mohammed Nuruddin is an Associate Professor at the University of Oslo, affiliated with the Department of Pharmacology and Pharmaceutical Biosciences. He leads the Oslo Imaging and Therapy Laboratory (OITL), managing its regulatory compliance and operations. His research focuses on preclinical development of diagnostic PET tracers, radiopharmaceuticals, and advanced imaging techniques for diseases like cancer, neurological disorders, and cardiovascular conditions.
Education: PhD in Pharmacology (2014, Norwegian University of Life Sciences), European Master in Animal Breeding and Genetics (2009, Swedish University of Agricultural Sciences), and Doctor of Veterinary Medicine (2004, Shahjalal University of Science & Technology).
Research Interests: Nuruddin specializes in PET tracer development, radiopharmaceuticals, and preclinical imaging. His work bridges translational research between academia and industry, with a focus on improving diagnostics and drug discovery through advanced imaging technologies.
Publications: His recent work includes studies on MET kinase PET tracers, comparative PET imaging in multiple myeloma, and preclinical evaluations of cabozantinib. These contributions highlight advancements in radiotracer design and theranostic applications.
Awards: Recognized with the European Compliance Academy Award for Sterile Production Manager (2014-2017).
Collaborations: Engages with institutions like Bayer, Oslo Cyclotron Laboratory, and the Cognitive Health Research group to advance translational research. He promotes OITL's capabilities nationally and internationally.
Labs/Teams: Directs the OITL facility, which integrates radiopharmacy, PET-SPECT-CT imaging, and data analysis to support preclinical research and industry partnerships.
